Catalyst Wire Dossier Catalyst Wire Dossier

VYFEMLA

NORETHINDRONE AND ETHINYL ESTRADIOL · Lupin Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for VYFEMLA, covering 2013-09-26 to 2022-04-29. Get the full timeline:

Most recent: FDA Approved: VYFEMLA — Supplemental Application (Lupin Pharmaceuticals, Inc.)

See pricing